OTCMKTS:CRNCV Cerence (CRNCV) Stock Price, News & Analysis → Charles Payne’s Gift to Stock Investors (From Unstoppable Prosperity) (Ad) Free CRNCV Stock Alerts $9.65 -0.06 (-0.62%) (As of 04/29/2024 ET) Add Compare Share Share Today's Range$9.63▼$10.1250-Day Range$9.39▼$15.7552-Week Range$17.25▼$29.36Volume558,549 shsAverage Volume75,989 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Cerence alerts: Email Address Ad Unstoppable ProsperityCharles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET About Cerence Stock (OTCMKTS:CRNCV)Read More CRNCV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRNCV Stock News HeadlinesApril 24, 2024 | americanbankingnews.comCerence (OTCMKTS:CRNCV) Shares Up 1.5%March 30, 2024 | finance.yahoo.comVeritext Legal Solutions Offers Webinar on “AI and the Record for Reporters and Videographers”April 30, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.March 29, 2024 | msn.comHome minister: Rulers wanted tighter citizenship conditions; Bill not about denying humanitarian aspectMarch 16, 2024 | markets.businessinsider.comStrong Buy Rating for Enliven Therapeutics Backed by Innovative Drug Candidates and Financial StabilityMarch 12, 2024 | msn.comTiumBio seeks clearance for cancer therapy trial in South KoreaMarch 11, 2024 | finance.yahoo.comImugene progresses onCARlytics solid tumour trial to combination armFebruary 29, 2024 | morningstar.comCanadian Natural Resources Ltd CRCApril 30, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.February 12, 2024 | msn.comAdagene expands clinical partnership with Merck for colorectal cancer treatmentNovember 20, 2023 | forbes.comConvert Saudi Riyal To Costa Rican ColónNovember 16, 2023 | dailymail.co.ukEuro 'doomed to be a weak currency'November 16, 2023 | juniorminingnetwork.comCanter Resources Commences Trading on US OTC Under Symbol 'CNRCF'November 13, 2023 | finance.yahoo.comCanter Announces Definitive Agreement with Altitude VenturesNovember 13, 2023 | forbes.comConvert Bahraini Dinar To Costa Rican ColónNovember 12, 2023 | forbes.comConvert British Pound Sterling To Costa Rican ColónNovember 10, 2023 | forbes.comConvert Australian Dollar To Costa Rican ColónNovember 10, 2023 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - CRCNovember 10, 2023 | markets.businessinsider.comLyell Receives FDA Orphan Drug Designation For LYL845November 3, 2023 | forbes.comConvert Costa Rican Colón To Canadian DollarNovember 2, 2023 | forbes.comConvert Croatian Kuna To Costa Rican ColónOctober 31, 2023 | forbes.comConvert Japanese Yen To Costa Rican ColónOctober 29, 2023 | msn.comAsian equities track Wall Street higherOctober 24, 2023 | forbes.comConvert Czech Koruna To Costa Rican ColónOctober 23, 2023 | forbes.comConvert Costa Rican Colón To Brazilian RealOctober 23, 2023 | forbes.comConvert Polish Zloty To Costa Rican ColónOctober 21, 2023 | forbes.comConvert Philippine Peso To Costa Rican ColónSee More Headlines Receive CRNCV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerence and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Packaged Software Sub-IndustryN/A Current SymbolOTCMKTS:CRNCV CUSIPN/A CIKN/A Webwww.cerence.com PhoneN/AFaxN/AEmployees1,300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key Competitors24SevenOffice Group AB (publ)OTCMKTS:TFSVFDivestcoOTCMKTS:DSVTFmCloud TechnologiesOTCMKTS:MCLDDRovio Entertainment OyjOTCMKTS:ROVVFView SystemsOTCMKTS:VSYMView All Competitors CRNCV Stock Analysis - Frequently Asked Questions How have CRNCV shares performed in 2024? Cerence's stock was trading at $19.66 at the beginning of 2024. Since then, CRNCV shares have decreased by 50.9% and is now trading at $9.65. View the best growth stocks for 2024 here. How do I buy shares of Cerence? Shares of CRNCV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRNCV) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsWhy Big Pharma is Investing Billions in This BiotechBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerence Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
